Nr1h2: A KEY TRANSCRIPTION FACTOR UNLOCKS NEW POTENTIAL IN STEM CELL-BASED EMBRYO MODELS
Read MoreIMPACT at IMCB: Fostering Postdoctoral Collaboration and Development
Celebrating IMCB's Success at SME Tech Day 2024
SCIENTISTS DISCOVER HOW EXCESSIVE RED MEAT CONSUMPTION INCREASES COLORECTAL CANCER RISK
Celebrating Mentorship Excellence: STAR Mentor Award 2024
Understanding How Enterovirus-A71 Causes Neurodegeneration in Human Motor Neurons
UNVEILING THE DIVERSITY OF MOTILE CILIA: A BREAKTHROUGH IN UNDERSTANDING CILIARY FUNCTION
IMCB Leads Collaborative Efforts at the SIMM-IMCB-ZIDD Joint Research Symposium: Advancing Biomedical Research Between China and Singapore
New research shows patients with rare cancers face increased risk of developing anxiety and depression
IMCB signs agreement with Cell Genesis Pte Ltd to advance cell therapy research for diabetes
A*STAR Scientists: Building Tomorrow's Science Today
REDUCING STRESS IN FARMED FISH: A NEW TOOL FOR IMPROVING AQUACULTURE PRACTICES
Revolutionizing Brain Cancer Treatment: Key Target Discovered by Our Research Team
NEW RESEARCH REVEALS LINK BETWEEN SPINAL MUSCULAR ATROPHY (SMA) AND LIVER DAMAGE
INTERNATIONAL RESEARCH TEAM UNVEILS IMPACT OF EAST ASIAN GENE VARIANT ON TYPE 2 DIABETES RISK
The surprising interplay between metabolism and mind
Scientists Discover How Deadly Skin Cancer Evades The Human Immune System
Congratulations to Associate Professor Su Xinyi on her official appointment as Executive Director of IMCB, effective from March 1, 2024.
Nurturing the next generation of scientific talents
Overcoming barriers in brain cancer